Journal of Gastroenterology

, Volume 41, Issue 9, pp 921–922

Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C

  • Masahiko Kaito
  • Motoh Iwasa
  • Yoshinao Kobayashi
  • Naoki Fujita
  • Hideaki Tanaka
  • Esteban C. Gabazza
  • Yukihiko Adachi
  • Yuji Kojima
  • Naoki Nakagawa
  • Shozo Watanabe
Letters to the editor

References

  1. 1.
    Farinati, F, Cardin, R, De Maria, N, Della Libera, G, Marafin, C, Lecis, E,  et al. 1995Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitisJ Hepatol2244956PubMedCrossRefGoogle Scholar
  2. 2.
    Sumida, Y, Nakashima, T, Yoh, T, Nakajima, Y, Ishikawa, H, Mitsuyoshi, H,  et al. 2000Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infectionJ Hepatol3361622PubMedCrossRefGoogle Scholar
  3. 3.
    Jain, SK, Pemberton, PW, Smith, A, McMahon, RF, Burrows, PC, Aboutwerat, A,  et al. 2002Oxidative stress in chronic hepatitis C: not just a feature of late stage diseaseJ Hepatol3680511PubMedCrossRefGoogle Scholar
  4. 4.
    Di Bisceglie, AM, Axiotis, CA, Hoofnagle, JH, Bacon, BR 1992Measurements of iron status in patients with chronic hepatitisGastroenterology102210813PubMedGoogle Scholar
  5. 5.
    Hayashi, H, Takikawa, T, Nishimura, N, Yano, M, Isomura, T, Sakamoto, N 1994Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis CAm J Gastroenterol899868PubMedGoogle Scholar
  6. 6.
    Kato, J, Kobune, M, Nakamura, T, Kuroiwa, G, Takada, K, Takimoto, R,  et al. 2001Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanousine levels in chronic hepatitis C patients by phlebotomy and low iron dietCancer Res618697702PubMedGoogle Scholar
  7. 7.
    Yano, M, Hayashi, H, Yoshioka, K, Saito, Y, Niitsu, Y, Kato, J,  et al. 2004A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in JapanJ Gastroenterol395704PubMedCrossRefGoogle Scholar
  8. 8.
    Gopaul, NK, Anggard, EE, Mallet, AI, Betteridge, DJ, Wolff, SP, Nourooz-Zadeh, J 1995Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitusFEBS Lett3682259PubMedCrossRefGoogle Scholar
  9. 9.
    Morrow, JD, Frei, B, Longmire, AW, Gaziano, JM, Lynch, SM, Shyr, Y,  et al. 1995Increase in circulating products of lipid peroxidation (F2-isoptostanes) in smokers. Smoking as a cause of oxidative damageN Engl J Med3321198203PubMedCrossRefGoogle Scholar
  10. 10.
    Urakawa, H, Katsuki, A, Sumida, Y, Gabazza, EC, Murashima, S, Morioka, K,  et al. 2003Oxidative stress is associated with adiposity and insulin resistance in menJ Clin Endocrinol Metab8846736PubMedCrossRefGoogle Scholar
  11. 11.
    Konishi M, Iwasa M, Araki J, Kobayashi Y, Sumida Y, Nakagawa N et al. Increased lipid peroxidation in patients with nonalcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol 2006 (in press)Google Scholar

Copyright information

© Springer-Verlag Tokyo 2006

Authors and Affiliations

  • Masahiko Kaito
    • 1
  • Motoh Iwasa
    • 1
  • Yoshinao Kobayashi
    • 1
  • Naoki Fujita
    • 1
  • Hideaki Tanaka
    • 1
  • Esteban C. Gabazza
    • 1
  • Yukihiko Adachi
    • 1
  • Yuji Kojima
    • 2
  • Naoki Nakagawa
    • 3
  • Shozo Watanabe
    • 4
  1. 1.Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical ScienceInstitute of Medical Science, Mie University Graduate School of MedicineTsuJapan
  2. 2.Department of Internal MedicineYamada Red Cross HospitalYamadaJapan
  3. 3.Department of Internal MedicineYokkaichi Social Insurance HospitalYokkaichiJapan
  4. 4.Health Administration CenterMie UniversityTsuJapan

Personalised recommendations